3,987
Total Claims
$400K
Drug Cost
275
Beneficiaries
$1,456
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-32%
Opioid rate vs peers
1.5% vs 2.2% avg
+3%
Cost per patient vs peers
$1,456 vs $1,411 avg
+22%
Brand preference vs peers
12.9% vs 10.6% avg
Opioid Prescribing
1.5%
Opioid Rate
61
Opioid Claims
$530
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 510 claims · $331K
Generic: 3,433 claims · $68K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 32 | $51K |
| Sitagliptin Phosphate | 21 | $32K |
| Semaglutide | 18 | $23K |
| Budesonide/Formoterol Fumarate | 35 | $19K |
| Apixaban | 25 | $18K |
| Insulin Detemir | 16 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $15K |
| Varicella-Zoster Ge/As01b/Pf | 26 | $5,294 |
| Icosapent Ethyl | 24 | $5,066 |
| Ticagrelor | 14 | $3,797 |
| Insulin Glargine,hum.Rec.Anlog | 15 | $3,740 |
| Esomeprazole Magnesium | 16 | $3,271 |
| Icosapent Ethyl | 12 | $3,181 |
| Duloxetine Hcl | 58 | $2,977 |
Prescribing Profile
Patient Profile
69
Avg Age
53%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About